Ending Workplace TB (EWTB) is delighted to mark World TB Day 2021 by announcing twelve new members.
EWTB’s founding corporate members, Johnson and Johnson, Fullerton Health, and Royal Philips, are joined by: Cepheid, Covance, Freeport-McMoRan, IQVIA, Otsuka, PerkinElmer, PRA Health Sciences, Qiagen, Recipharm, Sibanye-Stillwater, Société Générale, and VVF Life Sciences SA. Among them, the new members have operations and supply chains in many of the world’s highest TB-burden countries with potential to reach tens of thousands of workers with TB programming. We thank them all for joining and for demonstrating their commitment to tackling one of the world’s leading infectious killers.
EWTB has drawn heavily on the support of its non-corporate partners in bringing new players into the fight against TB. In addition to founding partners, the World Economic Forum; the Global Fund to Fight HIV/AIDS, TB and Malaria; the Stop TB Partnership; the Confederation of Indian Industry; and USAID India, EWTB now counts GBCHealth, High Lantern Group, India Health Fund, and Santé en Entreprise as partners.
Over the coming months, EWTB will continue to grow its network and support its members as they implement new interventions to enhance care and prevention of TB and other lethal respiratory pathogens in the workplace. We’ll also be establishing a collection of case studies and best practice resources from the efforts of our existing members.
EWTB will collaborate with each member to find the approach that makes most sense for their context and capabilities. Every company can play a role in the fight against TB. If you’re interested in finding out more, contact us at partners@ewtb.org
Full list of members as of 24th March 2021:
Cepheid, Covance, Freeport-McMoran, Fullerton Health, IQVIA, Johnson and Johnson, Otsuka, PerkinElmer, PRA Health Sciences, Qiagen, Recipharm, Royal Philips, Sibanye-Stillwater, Société Générale, and VVF Life Sciences SA.
Full list of partners as of 24th March 2021:
Confederation of Indian Industry, GBC Health, Global Fund to Fight HIV/AIDS, TB and Malaria, High Lantern Group, India Health Fund, Santé en Entreprise, Stop TB Partnership, USAID India, World Economic Forum
Comments